Literature DB >> 2259351

Sleep disorders and sleep effect in Parkinson's disease.

S A Factor1, T McAlarney, J R Sanchez-Ramos, W J Weiner.   

Abstract

It has been suggested that sleep may have a positive effect on morning motor symptoms in Parkinson's disease (PD). We examined this possibility and also looked at common sleep disorders in PD. Seventy-eight PD patients and 43 normal elderly subjects answered a questionnaire. Of the PD patients, 43.6% reported improved motor symptoms in the morning, 37.2% worse, and 19.2% unchanged compared to the rest of the day. No difference was found between morning-better and -worse groups with respect to age, duration or stage of PD; antiparkinsonian medications utilized, and predominant motor symptoms. However, the morning-same group had a shorter duration of PD and less severe disease and required fewer dopaminergic medications. Sleep disorders were seen with equal frequency in the morning-better and -worse groups. Our results suggest that sleep does not have a direct effect on morning motor function. Alterations in morning motor symptomatology probably represent a manifestation of motor fluctuations. Sleep fragmentation and spontaneous daytime dozing occurred much more frequently in PD patients than controls. In addition, nocturnal vocalizations and daytime hallucinations occurred only in the PD group.

Entities:  

Mesh:

Year:  1990        PMID: 2259351     DOI: 10.1002/mds.870050404

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  65 in total

1.  Treatment of insomnia in Parkinson's disease: a controlled trial of eszopiclone and placebo.

Authors:  Matthew Menza; Roseanne DeFronzo Dobkin; Humberto Marin; Michael Gara; Karina Bienfait; Allison Dicke; Cynthia L Comella; Charles Cantor; Lee Hyer
Journal:  Mov Disord       Date:  2010-08-15       Impact factor: 10.338

Review 2.  The Therapeutic Potential of Exercise to Improve Mood, Cognition, and Sleep in Parkinson's Disease.

Authors:  Gretchen O Reynolds; Michael W Otto; Terry D Ellis; Alice Cronin-Golomb
Journal:  Mov Disord       Date:  2015-12-30       Impact factor: 10.338

3.  Sleep and impulsivity in Parkinson's disease.

Authors:  Michael K Scullin; Ann B Sollinger; Julia Land; Cathy Wood-Siverio; Lavezza Zanders; Raven Lee; Alan Freeman; Felicia C Goldstein; Donald L Bliwise; Stewart A Factor
Journal:  Parkinsonism Relat Disord       Date:  2013-07-21       Impact factor: 4.891

4.  Risk of sleep-disordered breathing in Parkinson's disease.

Authors:  Wattanachai Chotinaiwattarakul; Praveen Dayalu; Ronald D Chervin; Roger L Albin
Journal:  Sleep Breath       Date:  2010-05-16       Impact factor: 2.816

5.  Changes in sleep electroencephalogram and nocturnal hormone secretion after administration of the antidyskinetic agent sarizotan in healthy young male volunteers.

Authors:  Heike E Kuenzel; Axel Steiger; Katja Held; Irina A Antonijevic; Ralf-Michael Frieboes; Harald Murck
Journal:  Psychopharmacology (Berl)       Date:  2005-02-17       Impact factor: 4.530

6.  Hallucinations, dreaming, and frequent dozing in Parkinson disease: impact of right-hemisphere neural networks.

Authors:  Karina Stavitsky; Patrick McNamara; Raymon Durso; Erica Harris; Sanford Auerbach; Alice Cronin-Golomb
Journal:  Cogn Behav Neurol       Date:  2008-09       Impact factor: 1.600

Review 7.  Sleep disturbances in Parkinson's disease.

Authors:  Matthew Menza; Roseanne DeFronzo Dobkin; Humberto Marin; Karina Bienfait
Journal:  Mov Disord       Date:  2010       Impact factor: 10.338

8.  Sleep dysfunction and its management in Parkinson's disease.

Authors:  Scott J Kutscher; Siavash Farshidpanah; Daniel O Claassen
Journal:  Curr Treat Options Neurol       Date:  2014-08       Impact factor: 3.598

9.  Nocturnal sleep enhances working memory training in Parkinson's disease but not Lewy body dementia.

Authors:  Michael K Scullin; Lynn Marie Trotti; Anthony G Wilson; Sophia A Greer; Donald L Bliwise
Journal:  Brain       Date:  2012-08-20       Impact factor: 13.501

Review 10.  Excessive daytime sleepiness and sleep disturbances in patients with neurological diseases: epidemiology and management.

Authors:  Svenja Happe
Journal:  Drugs       Date:  2003       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.